Skip to main content
. 2020 Dec 15;14(2):100984. doi: 10.1016/j.tranon.2020.100984

Fig. 3.

Fig 3

Extent of cell infiltration in tumor biopsies at baseline and during treatment (day 29) with vanucizumab for patients with a documented best overall response of progressive disease (PD) or stable disease (SD)a (n = 17) aNon-paired data points are shown for completeness where data points are missing. CD, cluster of differentiation.